Transplant International · 1988 · 22 citations · 3 references
Life SciencesImmunologyNephrologyKidney TransplantationTransplant ImmunologyTransplant SurgeryDonor-recipient CompatibilityHistocompatibilityHistocompatibility AntigensHla MatchingHla TypingMajor Histocompatibility ComplexHla Allele MatchingHla AllelesHla Antigen MatchingHla Antigen MismatchHla Matching In TransplantationHla Mismatch RecognitionTransplantation
Transplantation of kidneys bearing HLA antigens to which recipients have previously been exposed is generally avoided, and such prudence is a well-documented means of preventing early graft loss. Prior exposure and subsequent reactions can, however, take a wide variety of forms, and blanket avoidance may prevent many deserving patients from being transplanted. In our region, operating through a single tissue-typing laboratory, we follow a consistent policy of allowing retransplantation with kidneys bearing previous mismatches, provided no relevant antibody response has been detected. Twenty-one of 34 such transplants remain functioning at time periods ranging from 7 months to 7 years. Four were lost due to rejection within the 1st month, and the remaining 9 functioned for periods ranging from 2 months to 8 years. Three were lost for reasons other than rejection. Our antibody screening policy and our criteria for a negative crossmatch results in the exclusion of two-thirds of all repeat mismatch transplantations. The results indicate that in the remaining third, transplantation can be performed across a repeat mismatch with excellent long-term results, provided our defined crossmatch policy is adhered to strictly.
3
SUCCESSFUL RENAL TRANSPLANTATION IN PATIENTS WITH T-CELL REACTIVITY TO DONOR
Carl J. Cardella, M. Nicholson, J A Falk et al. · The Lancet · 1982 · 95 citations
B CELL ANTIBODIES AND CROSSMATCHING
George Ayoub, Min Park, Paul I. Terasaki et al. · Transplantation · 1980 · 49 citations